Zhejiang Medicine Co Ltd (600216) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin.

Total Cash From Operating Activities Chart for Zhejiang Medicine Co Ltd

Zhejiang Medicine Co Ltd (600216) operating cash flow for FY2025 was CNY 1.9B, a 54.2% change from FY2024. Zhejiang Medicine Co Ltd's operating cash flow grew from CNY 57.7M in 1998 to CNY 1.9B in 2025 (3167.3% over 27 years). Operating cash flow compound annual growth rate: 5-year CAGR of 8.5%, 10-year CAGR of 33.3%, 20-year CAGR of 24.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.